Carry-Forward Extension Helps Pressure BioSciences
Pressure BioSciences,
Inc. (NASDAQ: PBIO) is expected to receive approximately $623,000 in the form
of a tax refund from the government this year for the 2004 calendar year. The five-year
carry back of 2008 net operating losses are eligible for small businesses under the
American Recovery and Reinvestment Act of 2009, passed by Congress and signed into
law by President Obama in February 2009.
The new tax provision could help many companies posting losses last year to get refunds
for taxes paid as far back as five years earlier. The businesses could then re-file
their old tax returns, using the losses suffered last year to offset profits made
when times were good. The two year net operating loss carry-back provisions in 2002
provided much-needed relief to manufactures and Obama expanded it.
Pharmaceutical companies are likely to be the largest beneficiaries of this new law
given their rather unstable operating histories. A company with a profitable drug
for two of the last five years that sold it to fund a new drug in development may
now reach out and get tax refunds for those two years of profitability. This could
prove extremely valuable in today’s tough financing environment.
Another unintended consequence of this lengthening of the carry-forward may be in
mergers and acquisitions. Often times, larger profitable companies buy non-profitable
companies with promising assets to not only gain the assets, but also use the carry-forwards
to help offset their profits. Now, these carry-forwards are valid for the past five
years.
Related Stories
The above story is the opinion of the author only and it does not reflect
iStockAnalyst opinion. Further, the author is not personally advising you
regarding the suitability of the story for your investment needs. In no event
iStockAnalyst will be liable for any loss or damage including without
limitation, indirect or consequential loss or damage, or any loss or damage
whatsoever arising from or arising out of, or in connection with the use of this
information. Please consult your investment advisor before making any investment
decision.